8MB-13572-71674
2 vaccinations
2 coded responses
25 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 600 / IL
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Pfizer-BioNTech
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
- 2021-02-11
-
2021-02-12
Dose 2 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-27
- 2021-03-08
- 2021-03-12
-
2021-03-20
Survey response — day 35, dose 2MedDRA: Chemotherapy, Cough, Laboratory test abnormal, Office visit, Radiotherapy, Upper-airway cough syndrome — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professionalFree text: Symptoms: Cough & nasal drip. Blood lab work about 2-1/2 weeks showed anomalies in some immune system tests. I underwent chemo December 2019 and radiation Jan 2019 & Jan 2020. I have had multiple quarterly blood tests since the treatments. This was the 1st · Healthcare visit (other): Primary careMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Report sent to call center — day 35, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-26
-
2021-05-14
Survey response — 3 months, dose 2MedDRA: Pre-existing disease, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: During my routine health check up I have developed MDS - myelodysplastic syndrome. My lymphoma oncologist team believes it is from previous chemo & radiation treatments. My 2nd COVID vaccination was 2/12/21. MDS first appeared in lab work 3/1/21. · Healthcare visit (other): Scheduled follow up visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-15
-
2022-03-09
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech |
Call center
2 call center cases
2 successful
Free text
Release 6 — day 35, dose 2
Symptoms: Cough & nasal drip. Blood lab work about 2-1/2 weeks showed anomalies in some immune system tests. I underwent chemo December 2019 and radiation Jan 2019 & Jan 2020. I have had multiple quarterly blood tests since the treatments. This was the 1st cut off by CDC
Healthcare visit (other): Primary care
Release 8 — 3 months, dose 2
Symptoms: During my routine health check up I have developed MDS - myelodysplastic syndrome. My lymphoma oncologist team believes it is from previous chemo & radiation treatments. My 2nd COVID vaccination was 2/12/21. MDS first appeared in lab work 3/1/21. cut off by CDC
Healthcare visit (other): Scheduled follow up visit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Chemotherapy | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Laboratory test abnormal | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Radiotherapy | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release